Dosing of key TB drug rifampicin could go higher
Once-weekly continuation phase TB treatment equals standard of care
Dually active antiretroviral therapy protects against hepatitis B infection
Continuing cotrimoxazole in children on ART reduces the risk of hospitalisation
Black gay men run higher risk of HIV infection despite fewer partners
New NNRTI MK-1439 shows promise in early clinical trial
Dual CCR5/CCR2 inhibitor cenicriviroc has anti-inflammatory as well as anti-HIV effect
Small risk of neurological birth defects due to efavirenz confirmed in French cohort
HIV treatment for children is safe and highly effective without laboratory monitoring in large African trial
French studies report real-world data on use of telaprevir and boceprevir in people with HIV and hepatitis C co-infection
Very early antiretroviral treatment limits the size of HIV reservoir
Sofosbuvir/ledipasvir/ribavirin cures 100% of genotype 1 hepatitis C patients
Consistent condom use in anal sex stops 70% of HIV infections, study finds
Monthly injectable drug offers 100% protection against HIV in monkeys – could be dosed every three months
VOICE trial: disappointing result poses big questions for PrEP
Case report of a 'functional' HIV cure in a child
